(24/7 MARKET NEWS) – Vivos Therapeutics, Inc. (NASDAQ: VVOS) reported, this morning, a new FDA clearance for its proprietary DNA appliance (daytime-nighttime appliance). The third FDA clearance for Vivos’ oral appliances and first clearance specifically recognizing Vivos’ proprietary core technology.
Vivos is trading at $0.98, 24 cents higher (+32.43%), on 4.9 million shares traded.
Its 52-week range is $0.3411 to $3.69. Its premarket high is $1.30 and this morning is the first time it traded above a dollar since September. It may have a pullback before the regular session open.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.